159 related articles for article (PubMed ID: 33443975)
1. Performance With an Adhesive Bone Conduction Device in Active Transcutaneous Bone Conduction Implant Users.
Dahm V; Traxler S; Liepins R; Auinger AB; Sterrer E; Kaider A; Riss D; Arnoldner C
Otol Neurotol; 2021 Apr; 42(4):510-516. PubMed ID: 33443975
[TBL] [Abstract][Full Text] [Related]
2. Objective and subjective results of the Bonebridge transcutaneous active direct-drive bone conduction hearing implant.
Alzhrani F
Saudi Med J; 2019 Aug; 40(8):797-801. PubMed ID: 31423516
[TBL] [Abstract][Full Text] [Related]
3. Audiological and clinical outcomes of a transcutaneous bone conduction hearing implant: Six-month results from a multicentre study.
den Besten CA; Monksfield P; Bosman A; Skarzynski PH; Green K; Runge C; Wigren S; Blechert JI; Flynn MC; Mylanus EAM; Hol MKS
Clin Otolaryngol; 2019 Mar; 44(2):144-157. PubMed ID: 30358920
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up and review of the Bone Conduction Implant.
Reinfeldt S; Eeg-Olofsson M; Fredén Jansson KJ; Persson AC; Håkansson B
Hear Res; 2022 Aug; 421():108503. PubMed ID: 35490057
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Bonebridge BCI 602 active bone conductive implant in adults: efficacy and stability of audiological, surgical, and functional outcomes.
Cywka KB; Skarzynski PH; Krol B; Hatzopoulos S; Skarzynski H
Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3525-3534. PubMed ID: 35182185
[TBL] [Abstract][Full Text] [Related]
6. Safety and effectiveness of the Bonebridge transcutaneous active direct-drive bone-conduction hearing implant at 1-year device use.
Schmerber S; Deguine O; Marx M; Van de Heyning P; Sterkers O; Mosnier I; Garin P; Godey B; Vincent C; Venail F; Mondain M; Deveze A; Lavieille JP; Karkas A
Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1835-1851. PubMed ID: 27475796
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Audiological Results Between a Transcutaneous and a Percutaneous Bone Conduction Instrument in Conductive Hearing Loss.
Gerdes T; Salcher RB; Schwab B; Lenarz T; Maier H
Otol Neurotol; 2016 Jul; 37(6):685-91. PubMed ID: 27093021
[TBL] [Abstract][Full Text] [Related]
8. Active transcutaneous bone conduction hearing implants: Systematic review and meta-analysis.
Magele A; Schoerg P; Stanek B; Gradl B; Sprinzl GM
PLoS One; 2019; 14(9):e0221484. PubMed ID: 31525208
[TBL] [Abstract][Full Text] [Related]
9. First experiences with a new adhesive bone conduction hearing device in children.
Urík M; Hošnová D; Šlapák I; Jančíková J; Odstrčilík J; Jarkovský J; Baumgartner WD
Int J Pediatr Otorhinolaryngol; 2019 Nov; 126():109614. PubMed ID: 31377401
[TBL] [Abstract][Full Text] [Related]
10. A Comparative Study of a Novel Adhesive Bone Conduction Device and Conventional Treatment Options for Conductive Hearing Loss.
Skarzynski PH; Ratuszniak A; Osinska K; Koziel M; Krol B; Cywka KB; Skarzynski H
Otol Neurotol; 2019 Aug; 40(7):858-864. PubMed ID: 31295197
[TBL] [Abstract][Full Text] [Related]
11. Surgical and functional outcomes of two types of transcutaneous bone conduction implants.
Scotta G; Allam A; Dimitriadis PA; Wright K; Yardley M; Ray J
J Laryngol Otol; 2020 Dec; 134(12):1065-1068. PubMed ID: 33336637
[TBL] [Abstract][Full Text] [Related]
12. Multicentric study on surgical information and early safety and performance results with the Bonebridge BCI 602: an active transcutaneous bone conduction hearing implant.
Sprinzl G; Toner J; Koitschev A; Berger N; Keintzel T; Rasse T; Baumgartner WD; Honeder C; Magele A; Plontke S; Götze G; Schmutzhard J; Zelger P; Corkill S; Lenarz T; Salcher R
Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1565-1579. PubMed ID: 36625869
[TBL] [Abstract][Full Text] [Related]
13. Audiometric Comparison Between the First Patients With the Transcutaneous Bone Conduction Implant and Matched Percutaneous Bone Anchored Hearing Device Users.
Rigato C; Reinfeldt S; Håkansson B; Jansson KJ; Hol MK; Eeg-Olofsson M
Otol Neurotol; 2016 Oct; 37(9):1381-7. PubMed ID: 27631828
[TBL] [Abstract][Full Text] [Related]
14. Long-term data of the new transcutaneous partially implantable bone conduction hearing system Osia®.
Rauch AK; Wesarg T; Aschendorff A; Speck I; Arndt S
Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4279-4288. PubMed ID: 34792628
[TBL] [Abstract][Full Text] [Related]
15. A bone conduction implant using self-drilling screws : Self-drilling screws as a new fixation method of an active transcutaneous bone conduction hearing implant.
Koitschev A; Neudert M; Lenarz T
HNO; 2023 Aug; 71(Suppl 1):61-66. PubMed ID: 37322168
[TBL] [Abstract][Full Text] [Related]
16. Prediction of postoperative speech comprehension with the transcutaneous partially implantable bone conduction hearing system Osia®.
Arndt S; Wesarg T; Aschendorff A; Speck I; Hocke T; Jakob TF; Rauch AK
HNO; 2024 Jan; 72(Suppl 1):1-9. PubMed ID: 37812258
[TBL] [Abstract][Full Text] [Related]
17. Patient-reported long-term benefit with an active transcutaneous bone-conduction device.
Hundertpfund J; Meyer JE; Óvári A
PLoS One; 2020; 15(11):e0241247. PubMed ID: 33137128
[TBL] [Abstract][Full Text] [Related]
18. The bone conduction implant BONEBRIDGE increases quality of life and social life satisfaction.
Irmer C; Volkenstein S; Dazert S; Neumann A
Eur Arch Otorhinolaryngol; 2022 Dec; 279(12):5555-5563. PubMed ID: 35524069
[TBL] [Abstract][Full Text] [Related]
19. Preliminary functional results and quality of life after implantation of a new bone conduction hearing device in patients with conductive and mixed hearing loss.
Ihler F; Volbers L; Blum J; Matthias C; Canis M
Otol Neurotol; 2014 Feb; 35(2):211-5. PubMed ID: 24448279
[TBL] [Abstract][Full Text] [Related]
20. Three-Year Follow-Up with the Bone Conduction Implant.
Persson AC; Reinfeldt S; Håkansson B; Rigato C; Fredén Jansson KJ; Eeg-Olofsson M
Audiol Neurootol; 2020; 25(5):263-275. PubMed ID: 32268333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
